Clinical Trials

Inclusion Criteria:

Anosmia

• Olfactory Threshold Test scores corresponding to Anosmia or Hyposmia.
• Confirmed SARS-COVID 2 infection with documentation.
• Symptoms consistent with PCS lasting at least 1 month after the positive test date.

Tinnitus

• Audiological scores corresponding to a diagnosis of Tinnitus (not present prior to SARS-COVID 2 infection).
• Confirmed SARS-COVID 2 infection with documentation.
• Symptoms consistent with PCS lasting at least 1 month after the positive test date.

Fatigue

• Total MFIS Score of 40 or above.
• Confirmed SARS-COVID 2 infection with documentation.
• Symptoms consistent with PCS lasting at least 1 month after the positive test date.

Exclusion Criteria: 

• Implanted electronic devices, including pacemakers, defibrillators, implant medication pumps, or vagus nerve stimulators.
• Active alcohol abuse: > 14 drinks a week or formal diagnosis, illicit drug use or drug abuse.
• EEG abnormalities that indicate risk of seizure; i.e., abnormal focal or general slowing or spikes during the EEG recording.
• Any seizure history within the past 10 years.
• Intracranial implant within 30cm of magnet (e.g., aneurysm clips, envascular coil, cerebral shunts, brain stimulators, cochlear implants, stents, or electrodes) or any other metal object within or near the head, excluding the mouth, which cannot be safely removed.
• Enrolled or plans to enroll in an interventional trial during this study.
• Previous stroke with residual deficits.
• Subjects unable to comprehend or follow verbal commands.
• Subjects unable to comprehend and sign the informed consent.
• Based on PI’s or local physician’s assessment patient unable to tolerate the trial procedure due to medical condition.
• Clinical abnormality or clinically unstable medical condition, as indicated by medical history, physical examination, EKG results, or clinical laboratory testing, that in the Investigator’s judgment might pose a potential safety risk to the subject or limit interpretation of the trial results.
• Pregnant or trying to become pregnant; negative urine pregnancy test at screening will be required for females of child-bearing potential.
• Any condition which in the judgment of the investigator would prevent the subject from completion of the study.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/3/22. Questions regarding updates should be directed to the study team contact.